ASCO Breakthrough 2023

By

August 15, 2023

Researchers found that ctDNA testing increases the prognostic value of BRAF and microsatellite status in patients with colorectal cancer.

By

Hibah Khaja, PharmD

August 11, 2023

Phase 3 trial results suggest that it’s time to move away from using dexamethasone as an antiemetic, said Venkatraman Radhakrishnan, MD.

By

Hibah Khaja, PharmD

August 10, 2023

Pembrolizumab has demonstrated significant efficacy in patients with advanced neuroendocrine tumors, according to researchers.

By

Julie Ehlers

August 9, 2023

A blood-based test called SPOT-MAS can determine the presence and location of multiple cancers, a new study suggests.

By

Erin Clancy

August 9, 2023

LGBTQ+ adolescents and young adults with cancer face unique challenges in the health care setting, a review suggests.

By

August 9, 2023

Certain factors may increase the risk of severe COVID-19 in patients with cancer, research suggests.

By

Hibah Khaja, PharmD

August 7, 2023

SeekInCare, a blood-based multi-cancer detection test, can detect more than 20 cancer types with high specificity, according to researchers.

By

August 4, 2023

Zanidatamab plus docetaxel demonstrated antitumor activity in patients with HER2+ breast cancer who had no prior treatment in the advanced setting.

Want to read more?